BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11012031)

  • 1. Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.
    Billard W; Binch H; Bratzler K; Chen LY; Crosby G; Duffy RA; Dugar S; Lachowicz J; McQuade R; Pushpavanam P; Ruperto VB; Taylor LA; Clader JW
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2209-12. PubMed ID: 11012031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.
    Wang Y; Chackalamannil S; Hu Z; Clader JW; Greenlee W; Billard W; Binch H; Crosby G; Ruperto V; Duffy RA; McQuade R; Lachowicz JE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2247-50. PubMed ID: 11055330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonists.
    Wang Y; Chackalamannil S; Hu Z; Greenlee WJ; Clader J; Boyle CD; Kaminski JJ; Billard W; Binch H; Crosby G; Ruperto V; Duffy RA; Cohen-Williams M; Coffin VL; Cox KA; Grotz DE; Lachowicz JE
    J Med Chem; 2002 Dec; 45(25):5415-8. PubMed ID: 12459007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788.
    Lachowicz JE; Duffy RA; Ruperto V; Kozlowski J; Zhou G; Clader J; Billard W; Binch H; Crosby G; Cohen-Williams M; Strader CD; Coffin V
    Life Sci; 2001 Apr; 68(22-23):2585-92. PubMed ID: 11392630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor.
    Kozlowski JA; Lowe DB; Guzik HS; Zhou G; Ruperto VB; Duffy RA; McQuade R; Crosby G; Taylor LA; Billard W; Binch H; Lachowicz JE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2255-7. PubMed ID: 11055332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel imidazole derivatives with subtype-selective antimuscarinic activity (2).
    Miyachi H; Kiyota H; Segawa M
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2163-8. PubMed ID: 9873506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-selectivity relationship for M2 selectivity between M1 and M2 of piperidinyl piperidine derivatives as muscarinic antagonists.
    Niu YY; Yang LM; Deng KM; Yao JH; Zhu L; Chen CY; Zhang M; Zhou JE; Shen TX; Chen HZ; Lu Y
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2260-6. PubMed ID: 17289384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.
    Mitsuya M; Kobayashi K; Kawakami K; Satoh A; Ogino Y; Kakikawa T; Ohtake N; Kimura T; Hirose H; Sato A; Numazawa T; Hasegawa T; Noguchi K; Mase T
    J Med Chem; 2000 Dec; 43(26):5017-29. PubMed ID: 11150173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, muscarinic blocking activity and molecular modeling studies of 4-DAMP-related compounds.
    Recanatini M; Tumiatti V; Budriesi R; Chiarini A; Sabatino P; Bolognesi ML; Melchiorre C
    Bioorg Med Chem; 1995 Mar; 3(3):267-77. PubMed ID: 7606388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol.
    Varoli L; Angeli P; Burnelli S; Marucci G; Recanatini M
    Bioorg Med Chem; 1999 Sep; 7(9):1837-44. PubMed ID: 10530931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzylidene ketal derivatives as M2 muscarinic receptor antagonists.
    Boyle CD; Chackalamannil S; Chen LY; Dugar S; Pushpavanam P; Billard W; Binch H; Crosby G; Cohen-Williams M; Coffin VL; Duffy RA; Ruperto V; Lachowicz JE
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2727-30. PubMed ID: 11133078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic M2 antagonists: anthranilamide derivatives with exceptional selectivity and in vivo activity.
    Clader JW; Billard W; Binch H; Chen LY; Crosby G; Duffy RA; Ford J; Kozlowski JA; Lachowicz JE; Li S; Liu C; McCombie SW; Vice S; Zhou G; Greenlee WJ
    Bioorg Med Chem; 2004 Jan; 12(2):319-26. PubMed ID: 14723952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship studies: M2 and CCR5 receptor antagonists.
    Boyle CD; Palani A
    Curr Top Med Chem; 2003; 3(10):1155-69. PubMed ID: 12769714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.
    Sagara Y; Sagara T; Mase T; Kimura T; Numazawa T; Fujikawa T; Noguchi K; Ohtake N
    J Med Chem; 2002 Feb; 45(4):984-7. PubMed ID: 11831911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of ether analogues as potent and selective M2 muscarinic receptor antagonists.
    Wang Y; Chackalamannil S; Chang W; Greenlee W; Ruperto V; Duffy RA; McQuade R; Lachowicz JE
    Bioorg Med Chem Lett; 2001 Apr; 11(7):891-4. PubMed ID: 11294385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and muscarinic M2 subtype antagonistic activity of unnatural ent-himbacine and an enantiomeric pair of (2'S,6'R)-diepihimbacine.
    Takadoi M; Terashima S
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2871-3. PubMed ID: 12270166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antimuscarinic activity and quantitative structure-activity relationship (QSAR) of tropinyl and piperidinyl esters.
    Xu R; Sim MK; Go ML
    Chem Pharm Bull (Tokyo); 1998 Feb; 46(2):231-41. PubMed ID: 9501459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
    Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
    J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists.
    Lewis LM; Sheffler D; Williams R; Bridges TM; Kennedy JP; Brogan JT; Mulder MJ; Williams L; Nalywajko NT; Niswender CM; Weaver CD; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Feb; 18(3):885-90. PubMed ID: 18178088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfide analogues as potent and selective M(2) muscarinic receptor antagonists.
    Wang Y; Chackalamannil S; Hu Z; McKittrick BA; Greenlee W; Ruperto V; Duffy RA; Lachowicz JE
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1087-91. PubMed ID: 11909724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.